Interventional Radiology Imaging

Which Central Venous Access Device Is Best for Renal Replacement Therapy Lasting Over 2 Weeks?

·
Which Central Venous Access Device Is Best for Renal Replacement Therapy Lasting Over 2 Weeks?

A 58-year-old patient with diabetic nephropathy presents with uremic symptoms and a GFR of 8 mL/min/1.73 m². The nephrology team has determined the need to initiate renal replacement therapy. Given the patient’s clinical status, it is anticipated that therapy will be required for more than two weeks, serving as a bridge to a more permanent access solution. As the consulting physician or trainee, you must decide on the most appropriate central venous access device to facilitate effective and safe hemodialysis. This article details the clinical workflow for this specific scenario, explaining why the American College of Radiology (ACR) Appropriateness Criteria rates a Tunneled dialysis catheter as Usually appropriate.

Who Fits This Clinical Scenario for Renal Replacement Therapy Access?

This guidance applies to a specific patient population: individuals with renal failure who require central venous access for renal replacement therapy (RRT), such as hemodialysis, continuous renal replacement therapy (CRRT), or plasmapheresis, where the anticipated duration of need is more than two weeks. This often includes patients with newly diagnosed end-stage renal disease (ESRD) who need a reliable bridge to a permanent arteriovenous fistula or graft, or patients with acute kidney injury (AKI) who are not expected to recover renal function within a short timeframe.

This workflow is distinct from several similar-sounding but clinically different scenarios:

  • Acute, Short-Term Need (< 2 weeks): A patient with AKI who is expected to recover quickly or needs emergent, temporary access falls into a different category. For that scenario, a nontunneled catheter is often sufficient.
  • Chemotherapy Administration: A patient with a cancer diagnosis requiring systemic therapy needs a device optimized for medication infusion, not high-flow RRT. A port or PICC would be considered under a different set of criteria.
  • Non-Dialysis Infusions in Chronic Kidney Disease: A patient with chronic kidney disease (CKD) who needs long-term antibiotics but not dialysis presents a unique challenge. The primary goal in that case is preserving peripheral and central veins for future dialysis access, making device selection (like a PICC) highly consequential and generally avoided.

Correctly identifying your patient’s anticipated duration of therapy is the critical first step in selecting the right device and avoiding future complications.

What Clinical Needs Are You Addressing with This Access Choice?

Unlike a diagnostic workup, selecting a central venous access device is about addressing a set of specific functional requirements and mitigating long-term risks. The “differential” here is a consideration of the patient’s physiological needs for successful RRT.

The most critical requirement is the ability to support high blood flow rates. Standard hemodialysis requires flow rates of 350-450 mL/minute to achieve adequate solute clearance. Central venous catheters designed for infusion (like PICCs or standard CVCs) have lumens that are too small and cannot sustain these rates, leading to ineffective dialysis and access failure. The device chosen must be specifically engineered for high-flow, high-volume extracorporeal circuits.

A second major consideration is durability and infection prevention. Since the access will be in place for weeks or months, it must be resistant to infection and dislodgement. A device with features that create a biological barrier to infection is far superior to a simple percutaneous line for this duration. The risk of catheter-related bloodstream infection (CRBSI) increases significantly with the duration of catheter use, making this a key factor in device selection.

Finally, and perhaps most importantly for this patient population, is the principle of long-term vein preservation. Patients with ESRD will likely require vascular access for the rest of their lives. The upper extremity and subclavian veins are invaluable real estate for creating future arteriovenous fistulas and grafts, which are the preferred forms of permanent access. Any device that damages or causes thrombosis in these vessels can permanently compromise a patient’s future access options. Therefore, the chosen device and insertion site must prioritize the preservation of this critical vascular anatomy.

Why Is a Tunneled Dialysis Catheter ‘Usually Appropriate’ for This Scenario?

The ACR designates a Tunneled dialysis catheter as Usually appropriate because its design directly addresses the core clinical needs of high flow, durability, and vein preservation for patients requiring RRT for more than two weeks.

A tunneled dialysis catheter is a large-bore, dual-lumen catheter specifically engineered for hemodialysis. Its large internal diameter easily accommodates the high flow rates required for effective treatment. The key feature is its placement: the catheter is “tunneled” under the skin from a chest wall exit site to the venous entry site (typically the internal jugular vein). This subcutaneous tunnel, combined with an integrated Dacron cuff that promotes tissue ingrowth, serves two vital functions. It secures the catheter, reducing the risk of accidental dislodgement, and it creates a formidable barrier against the migration of skin flora along the catheter tract, substantially lowering the risk of CRBSI compared to nontunneled lines.

In contrast, other devices are rated lower for this specific clinical context:

  • Nontunneled dialysis catheter: Rated as May be appropriate, this device is intended for short-term, emergent use (typically under 14 days). While it can provide the necessary flow rates, its percutaneous nature without a tunnel or cuff leads to a significantly higher rate of infection and dislodgement when used beyond this timeframe. It is a temporary bridge, not a medium-term solution.
  • PICC (Peripherally Inserted Central Catheter): Rated as Usually not appropriate, a PICC is a dangerous choice for any patient with advanced CKD who may need future dialysis. First, its small lumen cannot support dialysis flow rates. More critically, placing a PICC in the cephalic or basilic vein often leads to thrombosis and stenosis of the vessel, rendering it useless for future fistula or graft creation. This action can permanently eliminate a patient’s best access options and is considered a “never event” in many nephrology and vascular surgery practices.

Placement of a tunneled dialysis catheter is an interventional procedure performed using ultrasound and fluoroscopic guidance, which involves a small amount of ionizing radiation. A pre-procedural venogram may be performed with contrast if there is a clinical suspicion of central venous stenosis from prior catheters or devices.

What Is the Downstream Workflow After Placing a Tunneled Dialysis Catheter?

The placement of a tunneled dialysis catheter is the beginning of a longer clinical pathway focused on establishing permanent, reliable access for renal replacement therapy.

  • Successful Placement and Function: If the catheter is placed successfully and provides adequate flow rates, the patient can begin or continue hemodialysis immediately. The catheter functions as a crucial “bridge,” allowing for effective treatment while the patient is evaluated for and awaits the creation and maturation of a permanent access, such as an arteriovenous fistula (AVF) or graft (AVG). The downstream workflow involves close coordination with nephrology and vascular surgery to plan for this definitive access.
  • Catheter Dysfunction (Poor Flow): If the catheter fails to provide adequate flow rates, the immediate next step is an evaluation for the cause. This typically involves a “catheter check” or “fistulogram” in interventional radiology, where contrast is injected through the catheter lumens under fluoroscopy. This can identify problems like a fibrin sheath, intraluminal thrombus, or positional occlusion against the vessel wall. Depending on the findings, interventions may include thrombolytic infusion (e.g., alteplase), balloon maceration of a fibrin sheath, or catheter exchange over a wire.
  • Suspected Catheter-Related Infection: If the patient develops fever, chills, or other signs of sepsis, a CRBSI must be suspected. The workup includes drawing paired blood cultures (one from each catheter lumen and one from a peripheral vein). If CRBSI is confirmed, treatment involves systemic antibiotics. Depending on the organism and clinical severity, the catheter may need to be removed or exchanged.

Pitfalls to Avoid (and When to Get Help)

Navigating access for patients with renal failure requires careful planning to avoid compromising future options. Here are common pitfalls:

  • Placing a PICC: Never place a PICC in a patient with CKD stage 4 or 5, or in any patient who may foreseeably need RRT, without first consulting nephrology. This can permanently damage veins needed for future life-sustaining access.
  • Using the Subclavian Vein: Whenever possible, the right internal jugular vein is the preferred insertion site. Using the subclavian vein for access carries a much higher risk of causing central venous stenosis, which can compromise the entire ipsilateral arm for future fistulas or grafts.
  • Ignoring Prior Access History: Failing to review a patient’s history of prior central lines can lead to difficult or failed placement attempts due to unrecognized central venous stenosis or occlusion.
  • Delaying Permanent Access Planning: A tunneled catheter is a bridge, not a destination. A common pitfall is relying on the catheter for too long without a clear and active plan for permanent access creation and maturation.

If you encounter difficulty with catheter placement, suspect central stenosis, or are managing a patient with a complex access history, escalate by consulting with an interventional radiologist or vascular surgeon.

Related ACR Topics and Tools

This article focuses on one specific clinical scenario. For a comprehensive overview of all variants and device considerations, please consult the parent topic article. For additional decision support, the following resources are available.

Frequently Asked Questions

Why is a tunneled catheter preferred over a nontunneled one if the duration is just over two weeks?

The key difference is the significantly lower risk of catheter-related bloodstream infection (CRBSI) with a tunneled catheter. The subcutaneous tunnel and Dacron cuff act as a barrier to infection, which is critical once the catheter is in place for more than 14-21 days. Nontunneled catheters have a much higher infection rate when used for this duration.

What is the ideal insertion site for a tunneled dialysis catheter?

The right internal jugular (IJ) vein is the preferred site. It offers a straight path to the superior vena cava and right atrium, minimizing kinking and positional occlusion. Most importantly, using the IJ vein avoids the subclavian veins, preserving them and reducing the risk of central venous stenosis, which could compromise the entire arm for future fistula or graft placement.

Can a patient with a tunneled dialysis catheter go home?

Yes. One of the primary advantages of a tunneled catheter is that it is a secure, durable access that allows for outpatient hemodialysis. Patients can be discharged from the hospital and come to a dialysis center for their treatments. This is in contrast to nontunneled catheters, which are typically managed only in an inpatient setting.

If a tunneled catheter is so good, why do we still need to create a fistula or graft?

While a tunneled catheter is the best bridge-to-dialysis option, it is still an indwelling foreign body with long-term risks, including infection, thrombosis, and central venous stenosis. Arteriovenous fistulas and grafts are considered permanent access because they use the patient’s own tissue (or a synthetic conduit) and have much lower long-term infection rates and better patency. The catheter should always be considered a temporary solution.

What if the patient has a history of multiple prior catheters and the internal jugular veins are occluded?

This is a complex access situation that requires expert consultation with interventional radiology or vascular surgery. Alternative access sites may be necessary, such as the external jugular veins, translumbar inferior vena cava, or transhepatic veins. A pre-procedural venogram is essential to map out the available venous pathways before attempting placement.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026